
How the South African COVID-19 variant was found
UC Riverside biomedical scientists were part of an international team that identified the coronavirus strain

What UC Riverside scientists have to say about vaccines, variants, and antibodies
Immunity generated by vaccination is better than immunity from an actual infection, says an expert

Remyelinating drug could improve vision in patients with multiple sclerosis
UC Riverside-led mouse study stresses MS treatment should be started early

Biomedical scientist explains how Covid-19 vaccines work
Dr. David Lo at the UC Riverside School of Medicine is an expert on vaccines

Observed COVID-19 variability may have underlying molecular sources
UC Riverside-led study shows how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity

Drug found to correct gene defect that causes immune-driven gut leakiness
UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells

Developing a COVID-19 vaccine at warp speed
Dr. Paul Offit, an international expert on vaccines, will give the 2020 Thomas and Salma Haider Biomedical Breakthrough Lecture at UC Riverside

Improving treatment of spinal cord injuries
Osmotic therapy device reduces swelling to prevent secondary injuries in rats

School of Medicine faculty receive grants to increase diversity in biomedical sciences, study incentives in research, boost mental health treatment
Total funding of three grants exceeds $1.2 million

Understanding a gene’s role in inflammatory bowel disease
UC Riverside mouse study will identify mechanisms the gene PTPN2 uses to affect gut cells

How the coronavirus could be prevented from invading a host cell
UC Riverside-led study shows inhibiting two host cell proteases can accomplish the task

Scientists to study how lungs respond to worm infections
Research supported by five-year NIH grant may have relevance for COVID-19 patients